Product NDC: | 0085-1288 |
Proprietary Name: | NASONEX |
Non Proprietary Name: | Mometasone furoate monohydrate |
Active Ingredient(s): | 50 ug/1 & nbsp; Mometasone furoate monohydrate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1288 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020762 |
Marketing Category: | NDA |
Start Marketing Date: | 19971001 |
Package NDC: | 0085-1288-01 |
Package Description: | 1 BOTTLE, PUMP in 1 CARTON (0085-1288-01) > 120 SPRAY, METERED in 1 BOTTLE, PUMP |
NDC Code | 0085-1288-01 |
Proprietary Name | NASONEX |
Package Description | 1 BOTTLE, PUMP in 1 CARTON (0085-1288-01) > 120 SPRAY, METERED in 1 BOTTLE, PUMP |
Product NDC | 0085-1288 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mometasone furoate monohydrate |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 19971001 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | MOMETASONE FUROATE MONOHYDRATE |
Strength Number | 50 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |